Skip to content

Clinical trials

Observational Glycogen Storage Disease Type II trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Phase: Observational Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20151
20161
20182
20212
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Unknown status2
Withdrawn2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LMU Klinikum4
Genzyme, a Sanofi Company3
CENTOGENE GmbH Rostock2
Amicus Therapeutics1
Centre for Analytical Biochemistry and Biomedical Mass Spectrometry1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II12
Myositis, Inclusion Body3
Myotonic Dystrophy2
Spinal Muscular Atrophies of Childhood2
Amyotrophic Lateral Sclerosis1
Anaphylaxis1
Friedreich Ataxia1
Fructose Metabolism, Inborn Errors1
Glycogen Storage Disease1
Glycogen Storage Disease Type I1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.